login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Bone Marrow Transplant Success Rate may be Improved by Inhibiting Cell Signaling Pathway
In a bed-side to bench approach, researchers at Cincinnati Children’s Hospital Medical Center report Sept. 26 in Nature Medicine that pharmacological inhibition of a signaling pathway triggered by Egfr (epidermal growth factor receptor) increased the mobilization of hematopoietic stem cells in mice. The finding provides a scientific basis for enhancing the effectiveness of autologous bone marrow transplants, in which the recipient donates his or her own stem cells prior to the procedure.
"Up to 10 percent of bone marrow donors fail to mobilize sufficient numbers of stem cells, which impedes autologous transplants and significantly delays transplant recovery time," said Hartmut Geiger, Ph.D., a researcher in the division of Experimental Hematology/Cancer Biology at Cincinnati Children’s and senior investigator on the study. "Our findings reveal a new rationale for targeted pharmacological approaches to improve stem cell mobilization and transplantation outcomes."
Autologous bone marrow transplant is often used to restore a person’s hematologic system after receiving radiation therapy for cancer treatment. Radiation exposure damages the system, which produces all of the body’s blood cell types – including those vital to immune system function.
In clinical hematopoietic stem cell (HSC) transplants, the preferred source for mobilizing hematopoietic stem cells from bone marrow into peripheral circulating blood is by targeting a signaling protein called granulocyte colony stimulating factor, or G-CSF. G-CSF stimulates bone marrow so that it releases HSCs into circulating peripheral blood. Mobilization failures and delayed recovery rates suggest the need for a deeper molecular understanding of the mobilization process to further improve the treatment.
|
|
|
More News on: Bone Marrow Biopsy, Leucopenia, Infantile Cortical Hyperostosis, Parkinsons Disease Surgical Treatment, Chronic Lymphocytic Leukemia, Hodgkins Lymphoma, Non-Hodgkins Lymphoma, Multiple Myeloma, Bone Marrow Transplantation, Transplantation
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
| News Categories: |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| » | US Spends Most on Healthcare Without Providing Superior Care |
| More Insurance News | |
|
Organ Donation Related News |
||||||||
| » | Five People in China Lead Better Lives After Receiving Organs from a Brain Dead Boy | » | Germany Aims To Increase Organ Donations With New Reforms | |||||
| » | World’s Smallest Artificial Heart Implanted in 16-Month-Old Baby | » | Infections May Be Lethal For Kidney Failure Patients | |||||
| » | Delhi’s First Heart Transplant Recipient Leads a Normal Life | » | Social Networks Could be an Effective Means to Seek Organ Donation | |||||
| » | Combo Antibiotic Therapy Does Not Lower Organ Failure Risk In Sepsis Patients | » | Oldest Living Kidney Donor in Britain at 83 Years | |||||
| Read More >> | ||||||||
